Feb 21, 2018 7:00am EST NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017
Jan 30, 2018 7:00am EST NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018
Dec 06, 2017 7:00am EST NeoGenomics Announces Six Clinical Data Presentations to be Made at the American Society of Hematology Meeting
